FDA Approvals in Oncology: January-March 2026
In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
Two of the nation’s preeminent leaders in cancer research and policy took the stage Sunday morning at the Opening...
Funded in partnership with the American Association for Cancer Research (AACR), our new Transatlantic Fellowships provide high-potential early-career researchers...
Back for March are the editors’ picks from the portfolio of scientific journals published by the American Association for...
Non-Hispanic black men in the United States are much more likely to develop prostate cancer and to die from...
Colorectal cancer is the second leading cause of cancer death in the United States. More than 50,000 people are...
Twenty years ago, the American Association for Cancer Research launched Women in Cancer Research (WICR), a membership group designed...
Stepping onto the exhibit floor at an Annual Meeting poster session is a memorable experience. Row upon row of...
Last Friday, March 8, 2019, marked another milestone in immuno-oncology: The U.S. Food and Drug Administration (FDA) announced the...
Each year, the American Association for Cancer Research (AACR) holds Early-career Hill Day, bringing a group of AACR Associate...
This year, the AACR Annual Meeting, the premier cancer research meeting in the world, is happening at the Georgia...